Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.
http://dlvr.it/SK4GzV
http://dlvr.it/SK4GzV
Comments
Post a Comment